Yes I agree with what you are saying in regards to the sp action. I for one was more focused on the EMA trials anyway in regards to timelines. The fda was always going to be a longer time frame, I know they were looking at a combination ema and fda this just makes me think the focus will go back on progressing with the ema. Fingers crossed ema are happy with trial design.
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-146
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
